3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
16
Thoracic
8
Breast
5
Head & Neck
4
Lymphoid
3
Other hematologic neoplasm
2
Gynecologic
2
Genitourinary
2
Sarcoma
1
Myeloid
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
355
Leukemia, Myeloid, Acute
297
Myeloproliferative Disorders
155
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
139
Precursor Cell Lymphoblastic Leukemia-Lymphoma
115
Primary Myelofibrosis
101
Leukemia, Myelomonocytic, Chronic
88
Lymphoma, Non-Hodgkin
76
Leukemia
69
Polycythemia Vera
61
Multiple Myeloma
55
Hodgkin Disease
50
Hematologic Neoplasms
48
Leukemia, Lymphocytic, Chronic, B-Cell
43
Lymphoma
40
Leukemia, Biphenotypic, Acute
40
Thrombocythemia, Essential
39
Myelodysplastic-Myeloproliferative Diseases
31
Neoplasms
29
Leukemia, Myeloid, Chronic-Phase
28
Anemia, Refractory, with Excess of Blasts
24
Recurrence
22
Anemia, Aplastic
21
Lymphoma, Mantle-Cell
20
Lymphoma, Follicular
20
Hematologic Diseases
20
Burkitt Lymphoma
20
Blastic Plasmacytoid Dendritic Cell Neoplasm
20
Blast Crisis
20
Histiocytosis, Langerhans-Cell
18
Interventions
nicotinamide-beta-riboside
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcopenia
×
Myeloid
×
1 year
×
Clear all
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled